How to Choose a Contract Supplement Manufacturer (CDMO): A 12-Point Checklist

Learning how to choose a contract supplement manufacturer is the one decision that decides whether your brand survives its first quality question. Your label, your price, your reviews, your Amazon India listing — all of it sits on top of a batch someone else made. If that batch is under-dosed, contaminated, or built on a cheaper substitute than the active on your panel, you find out when a customer, a buyer, or a regulator asks you to prove it.

A contract manufacturer — increasingly called a CDMO (contract development and manufacturing organisation) when it also formulates and runs R&D — is not a vendor you can swap like a courier. Changing one mid-run means re-testing, re-artworking (the manufacturer's name, address and FSSAI licence number sit on your label), and updating the manufacturer linked to your own FSSAI licence. So the vetting you do before you sign is the cheapest work you will ever do on the product.

This is a practical 12-point checklist for an Indian supplement founder. It is written to be used — real steps, real questions, and the numbers to ask for. MOQs, lead times, FSSAI, quick-commerce, export. Read it with a shortlist open.

The right way to choose a contract supplement manufacturer is to rank them on what they will put in writing, not on what they say on a call. Marketing decks describe intentions. A certificate, a test method, a signed quote, and a reference describe facts. Score every candidate on documents, not adjectives.

Three things separate a partner from a filler. Can they prove each batch is what the label says? Can they formulate with the exact branded, studied actives you want to claim? And will they commit their certifications, costs, and timelines to paper fast enough for you to plan a launch? The twelve points below are grouped around those three questions — quality, formulation, and commercials — plus the transparency that ties them together.

A note on language that protects you later: a supplement supports or aids normal function. It does not diagnose, treat, cure, or prevent disease, and in India a health supplement or nutraceutical label must not claim otherwise. A good manufacturer will keep your label and claims inside that line and flag copy that crosses it. If a factory is relaxed about this, that is a warning, not a convenience.

1. Certifications. Ask for the actual certificates, not logos on a website — WHO-GMP or GMP certification for the manufacturing site, the site's FSSAI licence (with health supplements / nutraceuticals endorsed for the right category), and ISO 22000 or FSSC 22000 for food-safety management. If you plan to sell into the Gulf or parts of Southeast Asia, ask about Halal certification — especially for gelatin capsules, softgels, and gummies — and about Kosher only if a buyer requires it. Check the certificate number, the issuing body, the scope (the specific dosage forms it covers), and the expiry date. A certificate scoped to tablets does not automatically cover gummies.

2. Per-batch COA, not skip-lot. This is the point that is easiest to skip and hardest to fix later. A Certificate of Analysis is a lot-specific report — identity (is the active what the label says), potency (how much per serving, by assay), and purity (heavy metals, microbial limits). Ask directly: do you test every batch, or one in five or ten? 'Skip-lot' testing samples some runs and infers the rest; it is cheaper, and it means the lot in your customer's hand may never have been tested. Make a per-batch COA a clause in the contract.

3. Third-party versus in-house testing. In-house QC is normal and fine for release testing. But for the claims that matter — the active's potency, the heavy-metals and microbial safety — an independent, accredited lab removes the 'we tested ourselves' problem. Ask who signs the COA and whether you receive it with the goods or have to email a portal for it. The answer tells you how much the factory wants you to actually read it.

4. Access to branded, patented actives. The clinical trial belongs to the brand, not the botanical. If you want to claim KSM-66® ashwagandha, Curcumin C3®, HIMABERB® berberine, Ferrochel® iron bisglycinate, K2VITAL® MK-7, or probiotic strains like HOWARU®, LGG®, or BB-12®, the manufacturer must have supply access to those named, standardized materials — and be able to document them on the COA and the supplier's paperwork. A generic extract of the 'same' herb does not carry the study, and your claim travels with the studied material, not the plant.

5. Dosage-form range. A single-form factory will push your product into the form it already runs. Decide the form from the customer and the active — a sensitive probiotic may need a capsule or stick-pack, a kids' product may need a gummy, a clinic line may want a sachet or an oral strip. Ask how many formats they can actually run: capsules, tablets, softgels, gummies, powders and premixes, liquids and drops, sachets and stick-packs, oral strips. More formats means you can extend the brand without changing partners.

6. Formulation and R&D depth. There is a real difference between a filler who runs your recipe and a CDMO who can develop one. Ask to see how they handle a new brief: can they do a prototype, stability data, and a dose rationale tied to the published human trial for each active? Under-dosing the named active below its studied dose is a common way a product quietly stops matching its own evidence. A partner who pushes back on an under-dose is protecting your claims.

7. MOQ you can actually fund. Minimum order quantity decides your first cheque and your cash-flow risk. A very large MOQ on a first SKU can bury a new brand in stock before it has proven demand. Ask for the MOQ per form and per SKU, and whether there is a lower pilot run for a first order. Low MOQs let a new brand test a product on Amazon India or a quick-commerce shelf before committing to a full run.

8. Lead time, written down. Ask for the realistic timeline in weeks, broken into stages: formulation and sampling, raw-material and branded-active procurement, production, QC and COA, packaging, and dispatch. Branded actives and printed packaging are often the long poles. Get it in writing, because a launch date, an influencer calendar, and a quick-commerce listing all hang off it.

9. Packaging and compliance support. The carton is where India's rules bite. Under FSSAI you need the FSSAI logo and licence numbers, the brand owner's and manufacturer's names and addresses, the category name (such as 'HEALTH SUPPLEMENT' or 'NUTRACEUTICAL'), the ingredient list, nutrition and active-ingredient quantities, allergen declarations, recommended usage and advisory warnings, and 'NOT FOR MEDICINAL USE' where the regulations require it. Legal Metrology adds its own items — net quantity, MRP, month and year of manufacture, and consumer-care details. Ask whether the manufacturer reviews artwork for compliance, and what packaging they can run — bottles, blisters, jars, pouches, mono-cartons. A factory that catches a label error before print saves you a reprint or a recall.

10. Export capability, for the markets you will actually sell in. If you plan beyond India — UAE, Saudi Arabia, the USA, Sri Lanka, Singapore, Nepal, Myanmar — each has its own registration, labelling, and documentation rules. Ask which markets they already ship to, and whether they provide the export paperwork: the per-lot COA, a Certificate of Free Sale, Halal where needed, and the format each regulator expects. A manufacturer already clearing goods into your target market has solved problems you have not met yet.

11. Transparency. Treat every 'trust us' as a cost. Will they show you the certificates, document the branded actives, explain the test methods, and give you a costed, itemised quote rather than a round number? A 'proprietary blend' that hides the dose of each active is the opposite of what you want — you cannot defend a claim you are not allowed to see. The more a partner is willing to document, the less you are carrying their risk.

12. References and a site check. Ask for two or three brands they currently manufacture for, and, where possible, speak to one. Ask for a recent (redacted) COA as a sample so you can see the real format and the actual methods. If you can, visit the site or ask for a documented audit. Fifteen minutes with a real reference will tell you more than fifteen pages of brochure.

Keep it short and specific. 'Do you test every batch with a third-party lab, and do I get the COA with the goods?' 'Can you source KSM-66® / Curcumin C3® / the specific branded active I want, and will you document it on the COA?' 'What is the MOQ per SKU and is there a pilot run?' 'What is the realistic lead time, stage by stage, in weeks?'

Then the commercials and compliance: 'Which markets do you already export to, and do you provide the registration paperwork?' 'Do you review my FSSAI and Legal Metrology label artwork before print?' 'Can you send a recent redacted COA and two brand references?' 'Can I have an itemised, costed quote — and how soon?'

Score each candidate out of twelve against the checklist above. The one that answers in documents, fast, and without flinching at the hard questions is usually the one still standing when your product faces its first real scrutiny.

Here is how we line up against this list. Insignis Bioscience is a private-label and custom supplement CDMO in India, working asset-light across an audited WHO-GMP partner network. We formulate with the branded actives founders want to claim — KSM-66®, Curcumin C3®, HIMABERB®, Ferrochel®, K2VITAL®, and the HOWARU® / LGG® / BB-12® probiotic strains.

On the point founders most often get burned by: every batch is tested, and every lot gets its own Certificate of Analysis. We run 8 dosage formats with 44+ ready-to-brand formulas, keep MOQs low so a new brand can start without over-committing, and serve 8 markets — India, UAE, Saudi Arabia, the USA, Sri Lanka, Singapore, Nepal, and Myanmar.

And on transparency: tell us the product and the markets, and we return a costed quote in two business days. Use the twelve points on us the same way you would on anyone else — that is the point of the list.